16:09 (GMT +7) - Monday 17/06/2019


Pfizer Vietnam partners with Medochemie

Released at: 14:27, 11/01/2019

Pfizer Vietnam partners with Medochemie

Photo: Pfizer Vietnam

Partnership to transfer technology for manufacturing Pfizer's innovative medicines in Vietnam.

by Ngoc Lan

Pfizer Vietnam announced a partnership with Medochemie on January 10 in Hanoi on technology transfer to manufacture Pfizer’s innovative medicines in Vietnam.

Medochemie, which has its own manufacturing plant in southern Binh Duong province, will follow international high-quality standards for manufacturing Pfizer’s products in the therapeutic areas of anti-infective, cardiovascular, and pain.

Pfizer will also provide on-ground support resources, including quality subject matter and technical transfer experts to facilitate effective technology transfer of these essential, life-saving medicines.

The partnership is aligned with the Vietnamese Government’s vision to boost and promote the development of the local pharmaceutical industry. It brings Pfizer’s global technology and operations platform of hard-to-make products such as sterile injectables to Vietnam and will help raise local manufacturing standards to that of international developed markets.

Mr. Bradley Allen Silcox, Chief Representative of Pfizer Thailand in Vietnam, said that the partnership with Medochemie reflects their commitment to Vietnam. “We are grateful to the Ministry of Health and the government for their vision of improving the capacity of the pharmaceutical sector and for creating an ecosystem that gives patients quality care and treatment,” he added. “We also strongly believe that Vietnam has the potential to develop into an ASEAN hub for the manufacture of innovative pharmaceutical products. We will continue to work in areas of research and development as well as local capacity building to bring our oncology and sterile injectable medicines, among other products, which will not only meet market demand but also contribute to developing a better local life sciences sector.”

Ms. Daphne Pittas, Member of the Board of Director at Medochemie, said the partnership provides impetus to the local pharmaceutical industry’s capabilities in manufacturing complex medicines such as oral dosage and injectable cephalosporin.

She also noted that Medochemie strongly believes in and will continue to support the scientific and technological advancement of Vietnam’s pharmaceutical sector.

Pfizer provides science and global resources to bring therapies to people that extend and significantly improve their lives.

From Europe, Medochemie provides affordable healthcare to every human being across the globe. Beginning in 2009, Medochemie has invested $100 million in Vietnam to develop three state-of-the-art pharmaceutical production facilities with a total area of 63,500 sq m, including at the Vietnam - Singapore Industrial Park 2 in Binh Duong province.

The company has also successfully transferred to Vietnam more than 98 formulations to operate technology and provide production know-how.

User comment (0)

Send comment